Penumbra ROA 2014-2018 | PEN
Current and historical return on assets (ROA) values for Penumbra (PEN) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Penumbra ROA for the three months ending June 30, 2018 was 2.35%.
| Penumbra ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2018-06-30 | $0.03B | $0.50B | 5.61% |
| 2018-03-31 | $0.01B | $0.49B | 2.60% |
| 2017-12-31 | $0.00B | $0.48B | 0.90% |
| 2017-09-30 | $-0.01B | $0.46B | -1.75% |
| 2017-06-30 | $0.01B | $0.42B | 1.39% |
| 2017-03-31 | $0.01B | $0.42B | 3.06% |
| 2016-12-31 | $0.02B | $0.31B | 5.15% |
| 2016-09-30 | $0.02B | $0.30B | 6.43% |
| 2016-06-30 | $0.01B | $0.28B | 2.22% |
| 2016-03-31 | $0.00B | $0.28B | 1.00% |
| 2015-12-31 | $0.00B | $0.26B | 0.76% |
| 2015-09-30 | $0.00B | $0.26B | 0.00% |
| 2015-06-30 | $-0.00B | $0.00B | inf% |
| 2015-03-31 | $0.00B | $0.00B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $4.709B | $0.334B |
| Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $91.495B | 21.95 |
| Intuitive Surgical (ISRG) | United States | $57.359B | 56.66 |
| Edwards Lifesciences (EW) | United States | $30.449B | 34.30 |
| Fresenius Medical Care (FMS) | Germany | $24.786B | 17.51 |
| IDEXX Laboratories (IDXX) | United States | $18.911B | 57.47 |
| ABIOMED (ABMD) | United States | $16.264B | 133.24 |
| DexCom (DXCM) | United States | $11.398B | 0.00 |
| Teleflex (TFX) | United States | $11.146B | 26.51 |
| Hologic (HOLX) | United States | $11.111B | 18.90 |
| Varian Medical Systems (VAR) | United States | $9.538B | 24.01 |
| STERIS (STE) | United Kingdom | $9.020B | 24.81 |
| Masimo (MASI) | United States | $6.006B | 39.99 |
| LivaNova (LIVN) | United Kingdom | $5.520B | 32.92 |
| Integra LifeSciences Holdings (IART) | United States | $5.328B | 27.57 |
| Globus Medical (GMED) | United States | $5.162B | 34.34 |
| Inogen (INGN) | United States | $4.171B | 110.38 |
| Cantel Medical (CMD) | United States | $3.475B | 35.01 |
| Wright Medical Group (WMGI) | Netherlands | $2.936B | 0.00 |
| Halyard Health (AVNS) | United States | $2.817B | 23.18 |
| Integer Holdings (ITGR) | United States | $2.376B | 21.52 |
| Glaukos (GKOS) | United States | $2.094B | 0.00 |
| Opko Health (OPK) | United States | $2.010B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.921B | 0.00 |
| Mazor Robotics (MZOR) | Israel | $1.525B | 0.00 |
| Nevro (NVRO) | United States | $1.515B | 0.00 |
| AxoGen (AXGN) | United States | $1.284B | 0.00 |
| Luminex (LMNX) | United States | $1.267B | 37.38 |
| K2Ms (KTWO) | United States | $1.192B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $1.182B | 201.47 |
| CryoLife (CRY) | United States | $1.176B | 103.19 |
| Orthofix (OFIX) | United States | $1.065B | 32.44 |
| Natus Medical (BABY) | United States | $1.037B | 22.00 |
| TransEnterix (TRXC) | United States | $0.924B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.906B | 0.00 |
| Intersect ENT (XENT) | United States | $0.855B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.748B | 26.16 |
| ViewRay (VRAY) | United States | $0.714B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.699B | 43.21 |
| Sientra (SIEN) | United States | $0.633B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.578B | 0.00 |
| Neuronetics (STIM) | United States | $0.437B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.420B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.414B | 0.00 |
| Veracyte (VCYT) | United States | $0.353B | 0.00 |
| Quotient (QTNT) | Switzerland | $0.351B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.326B | 0.00 |
| Accuray (ARAY) | United States | $0.312B | 0.00 |
| Nuvectra (NVTR) | United States | $0.296B | 0.00 |
| Fluidigm (FLDM) | United States | $0.294B | 0.00 |
| RTI Surgical (RTIX) | United States | $0.290B | 57.13 |
| IRadimed (IRMD) | United States | $0.277B | 99.88 |
| Corindus Vascular Robotics (CVRS) | United States | $0.257B | 0.00 |
| SeaSpine Holdings (SPNE) | United States | $0.243B | 0.00 |
| CRH Medical (CRHM) | Canada | $0.230B | 28.82 |
| T2 Biosystems (TTOO) | United States | $0.207B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.205B | 0.00 |
| Invuity (IVTY) | United States | $0.178B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.163B | 0.00 |
| RA MEDICAL SYST (RMED) | United States | $0.162B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.135B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.133B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.123B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.110B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.105B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.101B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.090B | 0.00 |
| EDAP TMS (EDAP) | France | $0.077B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.077B | 0.00 |
| ConforMIS (CFMS) | United States | $0.059B | 0.00 |
| Restoration Robotics (HAIR) | United States | $0.056B | 0.00 |
| Electromed (ELMD) | United States | $0.056B | 27.79 |
| OBALON THERPTCS (OBLN) | United States | $0.046B | 0.00 |
| Navidea Biopharmaceuticals (NAVB) | United States | $0.045B | 0.00 |
| Neovasc (NVCN) | Canada | $0.043B | 0.00 |
| Xtant Medical Holdings (XTNT) | United States | $0.043B | 0.00 |
| Vermillion (VRML) | United States | $0.036B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.035B | 0.00 |
| PAVmed (PAVM) | United States | $0.031B | 0.00 |
| Titan Medical (TMDI) | Canada | $0.028B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.027B | 0.00 |
| Dynatronics (DYNT) | United States | $0.024B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.023B | 0.00 |
| Presbia (LENS) | Ireland | $0.021B | 0.00 |
| American Shared Hospital Services (AMS) | United States | $0.019B | 14.91 |
| Nanovibronix (NAOV) | United States | $0.017B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.016B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.016B | 0.00 |
| Bioanalytical Systems (BASI) | United States | $0.016B | 0.00 |
| Avinger (AVGR) | United States | $0.013B | 0.00 |
| Micron Solutions (MICR) | United States | $0.010B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.008B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.008B | 0.00 |
| Cesca Therapeutics (KOOL) | United States | $0.008B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.008B | 0.00 |
| InspireMD (NSPR) | Israel | $0.006B | 0.00 |
| Amedica (AMDA) | United States | $0.004B | 0.00 |
| EnteroMedics (RSLS) | United States | $0.000B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.000B | 0.00 |
